MEMORANDUM OPINION AND ORDER
Defendant AB Sciex Pte. Ltd. (“AB Sciex”) is a trademark licensee seeking to avoid arbitration with its trademark licensors, plaintiffs Life Technologies Corp. (“Life Tech”) and Applied Biosystems LLC (“Biosystems”). Life Tech and Biosystems initiated arbitration pursuant to an arbitration clause in an asset purchase agreement (the “Purchase Agreement”) by which AB Sciex’s affiliate, defendant DH Technologies Development Pte. Ltd. (“DH Tech”) purchased Life Tech’s mass spectrometry business. That agreement also required the parties to execute, or cause their affiliates to execute, a trademark license agreement. Ultimately, Life Tech and Biosystems licensed the trademarks to AB Sciex through a license agreement (the “License Agreement”) that does not contain an arbitration clause. Life Tech and Biosystems have since commenced arbitration proceedings against AB Sciex and DH Tech arising out of AB Sciex’s use of the trademarks. AB Sciex now moves to enjoin those proceedings as to it, arguing that it is not a signatory to any agreement containing an arbitration clause and that its use of the trademarks is governed exclusively by the License Agreement. AB Sciex is estopped from avoiding arbitra
BACKGROUND
The facts in this case are set forth in detail in the Court’s opinion denying plaintiffs’ motion for a preliminary injunction,
Life Technologies Corp. v. AB Sciex Pte. Ltd.,
No. 11 Civ. 325,
In 2009 Life Tech transacted to sell its mass spectrometry business to Danaher Corporation (“Danaher”), an affiliate of defendant DH Tech. On September 2, 2009, Life Tech, Danaher, and DH Tech signed the Purchase Agreement laying out the terms of the sale. (See generally Szekeres Decl. Ex. A.) The Purchase Agreement, by which DH Tech bought Life Tech’s mass spectrometry business for roughly $450 million, required that “[o]n or prior to the Closing (but subject to the Closing being consummated), (i) [DH Tech] shall, and shall cause its respective Affiliates 1 to, execute and deliver to [Life Tech] copies of the Ancillary Agreements to which such Person is a party....” (Id. § 7.8; see also id. § 4.2(a)(v), (b)(iv) (requiring the parties to deliver the Ancillary Agreements at Closing); Szekeres Decl. ¶ 11.)
The Purchase Agreement also contained a detailed section on dispute resolution. As relevant to the present motion, the parties agreed therein that
in the event of any dispute, controversy or claim arising out of, relating to or in connection with this Agreement or any other Transaction Document ... or the breach, termination or validity thereof or the negotiation, execution or performance thereof (a “Dispute”), the parties shall attempt to settle such Dispute in the first instance by mutual discussions between representatives of senior management of each party.
(Id. § 11.6(a).) Should a Dispute prove irresolvable through negotiation, then the dispute “shall be submitted to mediation in accordance with the JAMS International Mediation Rules.” (Id. § 11.6(b).) In turn, “[a]ny Dispute not timely resolved in accordance with Section 11.6(b) shall be finally and exclusively resolved by arbitration in accordance with the then-prevailing JAMS International Arbitration Rules and Procedures....” (Id. § 11.6(c).) The Transaction Documents referred to in Section 11.6(a) included the Purchase Agreement and all Ancillary Agreements. (Id. § 1.1 (defining “Transaction Documents”).)
One
of the
Ancillary Agreements was the License Agreement.
(Id.
§ 1.1 (defining “Ancillary Agreements”).) Life Tech and Biosystems executed that agreement with AB Sciex, a DH Tech affiliate, on January 29, 2010, the closing date of the Purchase Agreement.
(See generally
Szekeres Decl. Ex. B; Szekeres Decl. ¶ 10.) The agreement’s recitals noted the Purchase Agreement “whereby [DH Tech] has agreed to purchase, or cause affiliates to purchase, certain assets of [Life Tech and Biosystems] relating to [Life Tech and Biosystem’s] Mass Spec Business and Consumables Business.” (License Agreement at 1.) The recitals concluded, “NOW
In the License Agreement, Life Tech and Biosystems granted AB Sciex licenses to use certain trademarks in certain manners. Specifically, Life Tech and Biosystems granted AB Sciex (1) “a non-exclusive, limited worldwide, royalty-free and fully paid-up license” to use one set of marks; and (2) “an exclusive (even as to [Life Tech and Biosystems]), perpetual, worldwide, royalty-free and fully paid-up license” to use another set of marks. (Id. §§ 2.1, 2.2.) Both licenses were subject to certain limitations explained in detail in the License Agreement. (Id. §§ 2.1-2.8, 3.5.) The parties also “agree[d] that no additional consideration is owed or due to [Life Tech and Biosystems] for the rights granted to [AB Sciex] hereunder.” (Id. § 2.9.)
The License Agreement lacks a section explicitly addressing conflict resolution procedures, but does state (1) that the agreement “and any other writing signed by the parties that specifically references this Agreement constitute the entire agreement among the parties with respect to the subject matter hereof and supersede all prior agreements, understandings ... both written and oral, between the parties with respect to the subject matter hereof,” (id. § 9.1); and (2) that AB Sciex “acknowledges that monetary relief would not be an adequate remedy for a breach ... and that [Life Tech and Biosystems] shall be entitled to the enforcement of this Agreement by injunction, ... without prejudice to any other rights and remedies ....” (id § 9.4).
On January 18, 2011, plaintiffs brought this suit asserting claims for, inter alia, breach of contract pursuant to the License Agreement, trademark infringement, and related claims against AB Sciex, and breach of contract pursuant to the Purchase Agreement against DH Tech, and sought a preliminary injunction. The Court subsequently denied plaintiffs’ motion for a preliminary injunction.
On April 22, 2011, Life Tech and Biosystems filed a demand for arbitration with JAMS, naming both DH Tech and AB Sciex as respondents. (Szekeres Decl. ¶ 12; see also Szekeres Decl. Ex. C at 2, 5.) AB Sciex now moves to enjoin the arbitration as against it, arguing primarily that it never signed any agreement to arbitrate with Life Tech or Biosystems.
DISCUSSION
“Arbitration is a matter of contract, and therefore a party cannot be required to submit to arbitration any dispute which it has not agreed so to submit.”
Ragone v. Atlantic Video at Manhattan Center,
Plaintiffs here contend that AB Sciex must arbitrate under an estoppel theory.
2
“A nonsignatory may be es-
Four Second Circuit cases illuminate the difference between a benefit flowing directly from a contract and one flowing only from the contractual relations of other parties. In
Tencara Shipyard,
prospective ship owners contracted with an Italian shipyard to construct a racing yacht.
The circuit also applied estoppel in reversing the district court and compelling arbitration in
Deloitte Noraudit.
There Deloitte U.S. agreed with all of its worldwide affiliates to form Deloitte International, a process completed by contracting in 1988.
The Second Circuit has, of course, also found parties able to avoid arbitration and the doctrine of estoppel. In
MAG Portfolio,
MAG, the owner of a fifty-percent stake in three joint ventures known as the Old Merlins, sold its stake to MBAM in return for a limited percentage of future profits of the Old Merlins.
The point was more clearly made in
Thomsovr-CSF.
There ES and Rediffusion had signed an exclusive dealing agreement containing an arbitration clause. 64
Though the Second Circuit does not draw the distinctions explicitly, two appear to arise from the cases detailed above. First, benefits are direct — and therefore will lead to estoppel when knowingly exploited — when arising specifically from the unsigned contract containing the arbitration clause; and benefits are indirect — and therefore will not lead to estoppel even if knowingly exploited — when merely incidental to the contract’s execution.
Compare Tencara Shipyard,
The case at bar lies somewhere in the middle. But the Court concludes that AB Sciex, like the prospective yacht owners in Tencara Shipyard, knowingly exploited a direct benefit of a separate agreement containing an arbitration clause, and is therefore estopped from avoiding arbitration under that agreement.
Here, DH Tech signed the Purchase Agreement with Life Tech, containing an arbitration clause, for the sale of Life Tech’s mass spectrometry business to DH Tech. In addition, the agreement required that the parties or their affiliates execute the License Agreement.
(See
Purchase Agreement ¶ 7.8.) Subsequently, AB Sciex signed the License Agreement with Life Tech and Biosystems, not containing an arbitration clause, for the license of certain Life Tech and Biosystems trademarks to AB Sciex. And AB Sciex proceeded to use those trademarks in connection with it and DH Tech’s mass spectrometry operations and, allegedly, other businesses. True that AB Sciex is not a signatory to the Purchase Agreement. But the Purchase Agree
This benefit is not analogous to the one exploited in
Thomson^CSF
where the non-signatory was able to squeeze out its rival as an incidental result of its rival’s prior execution of an exclusive dealing agreement. Indeed, in that case the ultimate result was in direct contrast to the original parties’ intent. The situation at bar is, however, analogous to, though perhaps the converse of,
Tencara Shipyard.
There estoppel applied when (1) two parties’ first contract anticipated a second contract, which then contained an arbitration clause; (2) the second contract created a direct benefit to the party signed only to the first; and (3) the second contract was signed “for the purpose of completing business” under the first contract.
MAG Portfolio,
The
Deloitte Noraudit
case supports the Court’s conclusion for similar reasons. Because Deloitte Norway took benefits from Deloitte International’s settlement with Deloitte U.K. — namely, using the “Deloitte” name — and because Deloitte Norway knew of yet failed to oppose that settlement in any way, Deloitte Norway was bound to the settlement’s arbitration provision. Likewise here, AB Sciex, as an affiliate of DH Tech and because the License Agreement references it, undoubtedly knew of the Purchase Agreement which called for the execution of the License Agreement.
Cf. Best Concrete Mix Corp. v. Lloyd’s of London Underwriters,
AB Sciex knowingly accepted and exploited benefits provided for in, and contemplated by, a contract containing an arbitration provision. It executed the Li
The thrust of AB Sciex’s argument is that because its rights in the trademarks arise from the License Agreement, and because plaintiffs’ claims are grounded in that agreement, AB Sciex therefore cannot be bound to the Purchase Agreement’s arbitration provision. But the doctrine of estoppel is intended to address that precise issue; and the cases that apply it despite the existence of collateral agreements, including
Tencara Shipyard, Deloitte Noraudit,
and
Wu,
belie AB Sciex’s argument. Moreover, the cases cited by AB Sciex for support are readily distinguishable.
See MAG Portfolio,
By executing the License Agreement, contracting for the trademarks, and using the trademarks in commerce, all with the knowledge of the Purchase Agreement, AB Sciex has knowingly exploited the benefits of the Purchase Agreement. Accordingly, AB Sciex is estopped from avoiding arbitration under the Purchase Agreement’s arbitration provision despite not having signed the Purchase Agreement.
CONCLUSION
For the foregoing reasons, AB Sciex’s motion to enjoin arbitration [45] is DENIED.
SO ORDERED.
Notes
. Both the Purchase Agreement and the Trademark License Agreement define Affiliate as "with respect to any Person, any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such Person.” (Purchase Agreement § 1.1 (defining "Affiliate”); see Szekeres Decl. Ex. B § 1.2.)
.
Plaintiffs' Demand for Arbitration Before JAMS suggests two additional grounds for
. " 'Classification is a term of art in maritime contract law. It refers to the process by which a ship is inspected to make sure it is seaworthy and complies with various safety regulations.... Vessel classifications provide two major benefits for shipowners. First, insurance is much less expensive for classed ships than for non-classed ships. Second, many governments ... require a vessel classification before they will allow a craft to sail under their national flag.' "
Tencara Shipyard,
. The shipyard executed the classification contract with the classification society in March 1992.
Tencara Shipyard,
. AB Sciex also makes the argument that the doctrine of estoppel is not available when the benefit exploited is granted in an agreement with no arbitration clause. (See Def.'s Reply at 5) ("The existence of an agreement between the parties regarding the very subject matter of the dispute sets this case apart from those cases in which courts have looked to equitable theories to require a non-signatory to arbitrate. Plaintiffs do not cite a single case holding that the doctrine of equitable estoppel can be employed to rewrite an agreement that governs the underlying dispute (the [License Agreement]) by importing an arbitration provision from an agreement that does not govern the underlying dispute and that the party opposing arbitration did not sign (the [Purchase Agreement])." (emphasis in original).) Nor, however, does AB Sciex cite a single case explaining what difference this distinction makes. And indeed the Tencara Shipyard case appears quite clearly to demonstrate that it makes none.
